Skip to main content
. 2021 Nov 24;11(11):e055834. doi: 10.1136/bmjopen-2021-055834

Table 2.

Seroprevalence of anti-SARS-CoV-2 antibodies by participant characteristics

Characteristics Tested Seropositive Seroprevalence χ2 test
N n % P value
Age in years
 14–19 192 7 3.7 0.19
 20–24 588 42 7.1
 25–29 400 24 6.0
 30–34 210 9 4.3
 ≥35 56 1 1.8
ANC
 Hiwot Fana Hospital 695 35 5.0 0.260
 Haramaya Hospital 19 0 0.0
 Awoday Health Centre 733 48 6.6
Residence
 Urban 984 57 5.8 0.910
 Rural 461 26 5.6
Number of children
 None 520 32 5.8 0.370
 1–5 778 45 5.5
 6–10 55 6 9.8
Trimester of visit
 First 366 31 8.5 0.034
 Second 658 32 4.9
 Third 423 20 4.8
Comorbidities
 None 1439 81 5.6 0.019
 At least one* 8 2 25.0
COVID symptoms†
 No 1389 82 5.9 0.240
 Yes 51 1 2.0

*Chronic liver, renal, cardiovascular or ‘other’ disease.

†At least one of cough, fever, headache or difficulty breathing.

ANC, antenatal clinic.